Roche and Novartis Leading the Way with Continuous Manufacturing Technologies in Biologics 1. How is AI transforming biologics and drug discovery?
Artificial intelligence (AI) is significantly enhancing biologics development and drug discovery by speeding up research, improving precision, and reducing costs. AI-driven platforms enable predictive modeling, identify viable drug candidates, and accelerate timelines for clinical trials. Companies like Pfizer and Roche are at the...
0 Compartilhamentos
85 Visualizações